Babylon, a UK start-up, plans to “put an accessible and affordable health service in the hands of every person on earth” by putting artificial intelligence (AI) tools to work. Currently, the company has operations in the UK and Rwanda and hopes to expand to the Middle East, the United States, and China. The company’s strategy is to combine the power of AI with the medical expertise of humans to deliver unparalleled access to healthcare.
Services Babylon Offers
Babylon’s engineers, doctors, and scientists developed an AI system that can receive data about the symptoms someone is suffering from, compare the information to a database of known conditions and illnesses to find possible matches, and then identify a course of action and related risk factors. People can use the “Ask Babylon” feature to inquire about their medical concerns to get an initial understanding of what they might be dealing with, but this service is not intended to replace the expertise of a doctor or be used in a medical emergency.
In pursuit of its mission, Babylon offers a “talk to a doctor” service via its app, GP at Hand that provides 24/7 access to healthcare professionals through video or audio conferencing. The app can be downloaded from Google Play or the App Store. At the consultation, doctors can give medical advice, answer questions, discuss treatment, and can order prescriptions that can be delivered to a patient’s door. All of the patient’s clinical records are stored in a secure environment, and their health history can be accessed and referenced when it’s needed. If a patient needs to revisit their appointment, they can review the medical notes and replay a recording of the appointment at any time.
Another feature that is available on the app is Healthcheck. Built with the support of doctors, scientists and disease experts, this AI tool can take answers from questions about family history and a person’s lifestyle and compare it to the medical database to then create a health report and insights to help someone stay healthy.
Image Credit: Alias Studio/ Amanda Scott
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News This Week
WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19. Alpacas produce unique antibodies—called nanobodies—that can [...]
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a [...]
A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for this and other viral mutations [...]
Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers reporting in ACS' Nano Letters have designed DNA-based nanogels that only break down and [...]
The new technology behind Pfizer's and Moderna's coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine 'platform' they use transforms the body into a virus-zapping vaccine [...]
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level. Scientists from the University of Houston [...]
Virtual patients, vaccines, medicine-making biomachines and microneedles are examples of tech innovation that is meeting the moment to address the global health crisis. Health has been a strong focus for this year’s top 10 [...]
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said Monday that an early peek at the data on its [...]
The first coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis shows. The developers - Pfizer and BioNTech - described it as a "great day for science and humanity". [...]
Researchers led by the University at Buffalo (UB) have devised a new method that could enhance the effectiveness of vaccines against the novel coronavirus, the virus that is responsible for causing COVID-19. Jonathan F. Lovell, PhD, an [...]
On March 17 this year, a man was taken to hospital in Israel suffering from a dry cough and a loss of sense of smell. He developed a fever and felt tired but, after three [...]
One of the world’s leading Covid-19 experimental vaccines produces an immune response in older adults as well as the young, its developers say, raising hopes of protection for those most vulnerable to the coronavirus that [...]
Coronavirus tests performed in labs are the gold standard for accuracy and antigen tests are a fast and inexpensive alternative. But backers of a third type of test, developed by a Nobel Prize winner [...]
COVID-19 is a severe infectious disease that has claimed >150,000 lives and infected millions in the United States thus far, especially the elderly population. Emerging evidence has shown the virus to cause hemorrhagic and immunologic [...]
Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves. “We estimate that the capacity limit [...]